Archive for the 'Dermatology' Category
Xclair(R) Reported To Be Safe And Effective In Study Published In European Journal Of Dermatology
ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European Journal of Dermatology.
Original post by Women’s Health / Gynecology News From Medical News Today
European Commission Announces Marketing Authorisation For 50mg Once Weekly Enbrel(R) For Patients With Moderate-To-Severe Psoriasis
The European Commission announced a new 50mg Enbrel® (etanercept) once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel® twice weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis. Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorisation for the European Union for a once weekly 50mg Enbrel® dosing.
Original post by Women’s Health / Gynecology News From Medical News Today
Ultraviolet Light Therapy Is As favourable For Darker Skin As Lighter Skin
An analysis of more than 100 patients has confirmed for the first duration that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, UT Southwestern Medical Center researchers show. Phototherapy is the use of ultraviolet light to treat skin disorders, ranging from common problems such as acne and psoriasis to rarer conditions such as scleroderma and morphea, a hardening of the skin.
Original post by Women’s Health / Gynecology News From Medical News Today
Women Who Use Fake Tan Are Twice As Likely To Stay Safe In The Sun - 36% Of British Teens Class Themselves As Sun Worshippers
They may look like they would do anything for a perma-tan, but new research from iVillage.co.uk has found that women who use fake tan are twice as likely to use sun protection than those who don’t. Despite their desire for a sun-kissed look, 44% of women who wear fake tan say they always use sunscreen, whereas just 21% of women who prefer pale actually protect their skin from the sun.
Original post by Women’s Health / Gynecology News From Medical News Today
FDA Approves EVOLENCE®, A New Generation Collagen Based Facial Filler
The U.S. Food and Drug Administration (”FDA”) announced the approval of EVOLENCE® for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE® is a new advanced collagen-based structural dermal filler, and a first of its kind product. The introduction of EVOLENCE® marks the first dermal filler entry for the Aesthetics Group of OrthoNeutrogena.
Original post by Women’s Health / Gynecology News From Medical News Today
VioQuest Pharmaceuticals Submits 510(k) Application To FDA For Xyfid™, A Novel Topical Agent For The Treatment Of Various Skin Disorders
VioQuest Pharmaceuticals (OTCBB: VOQP) announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA).
Original post by Women’s Health / Gynecology News From Medical News Today
Substances Similar To The Body’s Own ‘Cannabis (Marijuana) Are essential For Healthy Skin And May Lead To New Skin Disease Treatments
Scientists from Hungary, Germany and the U.K. have discovered that our own body not only makes chemical compounds similar to the active ingredient in marijuana (THC), but these play an urgent part in maintaining healthy skin. that finding on “endocannabinoids” just published online in, and scheduled for the October 2008 print issue of, The FASEB Journal could lead to new drugs that treat skin conditions ranging from acne to dry skin, and even skin-related tumors.
Original post by Women’s Health / Gynecology News From Medical News Today
